What is Efaproxiral used for?

Efaproxiral is being studied for its potential to treat certain types of cancer, such as breast cancer and lung cancer.

How does Efaproxiral work in the body?

Efaproxiral works as a Hemoglobin HbA negative modulator.

Is Efaproxiral an approved drug for cancer?

Efaproxiral is currently in Phase 3 of clinical research and is not listed as an approved treatment in this data.

Can Efaproxiral treat brain tumors?

Research has looked into its use for Central Nervous System neoplasms, though it is at a lower phase of study for that area.

What type of molecule is Efaproxiral?

Efaproxiral is classified as a small molecule.

Is Efaproxiral a natural product?

Yes, Efaproxiral is noted as a natural product.

efaproxiral | CAS 131179-95-8 | BNFRJXLZYUTIII

Loading compound...

Hemoglobin modulator

Efaproxiral is a small molecule being studied for its ability to act as a Hemoglobin HbA negative modulator. It has been researched for potential use in treating various types of cancer, including breast and lung cancer, though it is currently in the research phase (Phase 3).

How it worksEfaproxiral works by modulating Hemoglobin HbA.

Used for

Breast cancerLung cancerOther neoplasms (tumors)

Conditions

Breast cancerLung cancerCentral Nervous System neoplasms

Class

Hemoglobin modulatorRespiratoryEndocrine

How to take

Efaproxiral is currently in clinical development (Phase 3) and is not yet a widely available approved medication for these indications.

Talk to your doctor

Questions to ask

·Is Efaproxiral part of a clinical trial I might qualify for?
·How does Efaproxiral's mechanism affect my hemoglobin levels?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.

How to take

Talk to your doctor

Frequently asked questions (6)